• Law Topics
    Litigation Transactional Law Law Firm Management Law Practice Management Legal Technology Intellectual Property Cybersecurity Browse All ›
  • Surveys & Rankings
    Amlaw 100 Amlaw 200 Global 200 NLJ 500 A-List Diversity Scorecard Browse All ›
  • Cases
    Case Digests Federal Court Decisions State Court Decisions
  • People & Community
    People & Community Q&A Career Annoucements Obituaries
  • Judges & Courts
    Part Rules Judicial Ethics Opinions Court Calendar Court Notes Decision - Download Court Calendar - Download
  • Public Notice & Classifieds
    Public Notices & Classifieds Place a Public Notice Search Public Notices Browse Classifieds Place a Classified
  • All Sections
    Events In Brief Columns Editorials Business of Law NY Top Verdicts Instant Insights Special Sections The Newspaper Special Supplements Expert Witness Search Lawjobs Book Center CLE Center Video Sitemap
    • Page Printed From:
    https://www.law.com/newyorklawjournal/2021/01/08/pharma-bro-martin-shkreli-loses-bid-to-delay-ftc-suit-until-release-from-prison-in-2023/
    Pharmaceuticals, appearing before the House Committee on Oversight and Government Reform during a hearing titled "Developments in the Prescription Drug Market," on Feb. 4, 2016. Shkreli, on the advice of his attorney, Ben Brafman, of Brafman & Associates, refused to answer any questions. Photo by Diego M. Radzinschi/THE NATIONAL LAW JOURNAL. Martin Shkreli, on Feb. 4, 2016. Photo by Diego M. Radzinschi/ALM

    NEWS

    'Pharma Bro' Martin Shkreli Loses Bid to Delay FTC Suit Until Release From Prison in 2023

    U.S. District Judge Denise L. Cote of the Southern District of New York rejected Shkreli's long-shot bid to stay discovery in the case, which was filed last January by the Federal Trade Commission and seven states, including New York.

    January 08, 2021 at 05:36 PM

    1 minute read

    X

    Thank you for sharing!

    Your article was successfully shared with the contacts you provided.

    NY AG James, FTC Seek Lifetime Ban for ‘Pharma Bro’ Martin Shkreli for ‘Monopolizing’ Drug

    NY AG James, FTC Antitrust Suit Against ‘Pharma Bro’ Martin Shkreli Clears Motion to Dismiss

    This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

    To view this content, please continue to their sites.

    Not a Lexis Subscriber?
    Subscribe Now

    Not a Bloomberg Law Subscriber?
    Subscribe Now

    Why am I seeing this?

    LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

    For questions call 1-877-256-2472 or contact us at [email protected]

    Law Firms Mentioned

    Law.com Pro

    More From ALM

    Premium Subscription
    With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas.
    View Now
    Team Accounts
    Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team.
    View Now
    Bundle Subscriptions
    Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same.
    View Now
    Go to CLE Center
    Consulting Best Firms to Work For 2024
    September 12, 2024
    New York, NY

    Consulting Magazine identifies the best firms to work for in the consulting profession.


    Learn More
    General Counsel Conference Southwest 2024
    September 18, 2024 - September 19, 2024
    Dallas, TX

    Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies


    Learn More
    Women, Influence & Power in Law US Awards 2024
    September 24, 2024
    Chicago, IL

    Women, Influence & Power in Law Awards honors women lawyers who have made a remarkable difference in the legal profession.


    Learn More
    Go to Events Go to Webcasts
    New Jersey Law Revision Commission Full-time staff attorney position

    The New Jersey Law Revision Commission, an independent legislative commission (N.J.S. 1:12A-1 et seq.), seeks a NJ-licensed atty in good sta...


    Apply Now ›
    Associate General Counsel for Litigation

    The Federal Election Commission (FEC) is looking for a passionate and dedicated individual with extensive litigation experience as well as o...


    Apply Now ›
    Finance/Corporate Trust Attorney - CT or Remote

    We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...


    Apply Now ›
    Go to Lawjobs